184 related articles for article (PubMed ID: 11956813)
1. Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis.
Tannapfel A; Wittekind C
Virchows Arch; 2002 Apr; 440(4):345-52. PubMed ID: 11956813
[TBL] [Abstract][Full Text] [Related]
2. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt.
Hussein MR
Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
[TBL] [Abstract][Full Text] [Related]
4. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE
Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213
[TBL] [Abstract][Full Text] [Related]
5. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
6. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
Feng D; Zheng H; Shen M; Cheng R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
[TBL] [Abstract][Full Text] [Related]
10. TP53 and liver carcinogenesis.
Staib F; Hussain SP; Hofseth LJ; Wang XW; Harris CC
Hum Mutat; 2003 Mar; 21(3):201-16. PubMed ID: 12619106
[TBL] [Abstract][Full Text] [Related]
11. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
Wang L; Huang J; Jiang M; Sun L
J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
[TBL] [Abstract][Full Text] [Related]
12. Proliferative drive and liver carcinogenesis: too much of a good thing?
Teoh NC
J Gastroenterol Hepatol; 2009 Dec; 24(12):1817-25. PubMed ID: 20002941
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of human hepatocellular carcinoma.
Thorgeirsson SS; Grisham JW
Nat Genet; 2002 Aug; 31(4):339-46. PubMed ID: 12149612
[TBL] [Abstract][Full Text] [Related]
14. Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma.
Lee TK; Man K; Poon RT; Lo CM; Ng IO; Fan ST
Oncol Rep; 2004 Jul; 12(1):25-31. PubMed ID: 15201954
[TBL] [Abstract][Full Text] [Related]
15. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
16. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY
Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600
[TBL] [Abstract][Full Text] [Related]
17. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro.
Lai PB; Chi TY; Chen GG
Apoptosis; 2007 Feb; 12(2):387-93. PubMed ID: 17191126
[TBL] [Abstract][Full Text] [Related]
18. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
[TBL] [Abstract][Full Text] [Related]
19. [Molecular biology and hepatocellular carcinoma: current status and future prospects].
Saffroy R; Pham P; Lemoine A; Debuire B
Ann Biol Clin (Paris); 2004; 62(6):649-56. PubMed ID: 15563423
[TBL] [Abstract][Full Text] [Related]
20. An update on the molecular genetics of hepatocellular carcinoma.
Suriawinata A; Xu R
Semin Liver Dis; 2004 Feb; 24(1):77-88. PubMed ID: 15085488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
